FDA Warning Letter — Hyphen BioMed Sasu
The FDA took a Warning Letter action against Hyphen BioMed Sasu on Sep 5, 2012 (Neuville-Sur-Oise, France). The action was issued by CDRH and concerns devices products. This facility has 2 recent FDA inspections on record.
Action details
- Facility
- Hyphen BioMed Sasu
- Date
- Sep 5, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Center
- CDRH
- Location
- Neuville-Sur-Oise (France)